Menu Search
Equities

JBM (Healthcare) Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2161:HKG.HS

JBM (Healthcare) Ltd

Actions
  • Price (HKD)2.64
  • Today's Change-0.05 / -1.86%
  • Shares traded481.75k
  • 1 Year change+41.94%
  • Beta0.4791
Data delayed at least 15 minutes, as of Feb 06 2026 08:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

JBM (Healthcare) Ltd is an investment holding company principally engaged in the development, manufacture and distribution of Chinese medicines. The Company operates its business through three segments. The Branded Medicines segment is engaged in the development, manufacture and distribution of branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment is engaged in the development, manufacture and distribution of registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal or mineral origin customarily or widely used by the Chinese. The Health and Wellness Products segment is engaged in the distribution and sale of supplements, medical consumables and other nonpharmaceutical products for the general health and wellness of consumers.

  • Revenue in HKD (TTM)812.98m
  • Net income in HKD216.39m
  • Incorporated2020
  • Employees412.00
  • Location
    JBM (Healthcare) LtdUnit 2303-07, 23/F, Tower 1, Millennium388 Kwun Tong Road, Kwun Tong, KowloonKOWLOON Hong KongHKG
  • Phone+852 22672178
  • Websitehttps://www.jbmhealthcare.com.hk/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.